All News

Lorcaserin observed to reduce opioid cravings.

A former physician and owner of a pain clinic in Atlanta, Georgia, has been sentenced for his involvement in a prescription painkiller distribution conspiracy, according to a Department of Justice press release.

Top news of the day from across the health care landscape.

Qudexy XR (topiramate) extended-release capsules approved for use as prophylaxis of migraine headaches.

The dream of an HIV cure will only be realized if all 35 million people who are living with the virus adhere to treatment.

Top news of the day from across the healthcare landscape.

In this column, I present my top 5 movie recommendations for pharmacy students.

Croup is a common illness among children that causes swelling of the larynx and trachea.

Unstandardized accounting methods can lead to differing profit margins for PBMs.

Strategic partnership will advance the use of data in value-based care.

Doxycycline disrupts the formation of negative associations in the brain that contribute to post-traumatic stress disorder (PTSD), a new study published in Molecular Psychiatry concluded.

Seventy-eight percent of older Americans support drug cost negotiation in Medicare.

Poorer health outcomes found in perinatally HIV-infected youth.

Variants of the IL7R and DDX39B genes may lead to increased risk of multiple sclerosis.

Pharmacist outreach may reduce opioid prescriptions.

Identification of genetic variants may improve diagnosis of MS.

Behavioral treatments may help reduce severity of symptoms for conditions such as Crohn’s disease.

Increased levels of a specific protein was associated with progression of amyotrophic lateral sclerosis.

Biovica’s DiviTum assay offers noninvasive tool to monitor efficacy of CDK4/6 inhibitors.

The Connected Care initiative will provide educational resources for providers and patients.

Top news of the day from across the healthcare landscape.

Countries where high risk populations face punitive laws do not have access to critical HIV prevention services.

Top news of the day from across the health care landscape.

Patients who have asthma and who are also obese carry a heavy burden.

The study population consisted of 148,981 infants born in Kaiser Permanente hospitals in Northern California from 2006-2015. The percentage of infants whose mothers received Tdap during pregnancy increased from less than 1% in 2006-2008, to nearly 12% in 2010, and over 87% by 2015.

Report from Magellan Rx Management shows high-cost specialty drugs require effective management of the medical benefit.

Austedo is the second product approved for Huntington’s Disease.

Medical pharmacy trend report shows significant impact from specialty drugs.

Austedo is the first deuterated product approved by the FDA for chorea associated with Huntington’s disease.